Literature DB >> 15147804

Synergistic penetration enhancement effect of ethanol and phospholipids on the topical delivery of cyclosporin A.

D D Verma1, A Fahr.   

Abstract

In the present study, ethanol was used with a commercially available lipid mixture, NAT 8539, to improve the topical delivery of cyclosporin A (CyA). The vesicles formed from this solution ranged from 56.6 to 100.6 nm in diameter, depending on the amount of ethanol added in the formulation. In-vitro skin penetration studies were carried out with Franz diffusion cell using human abdominal skin. There was a decrease in average size of vesicles, as the amount of ethanol in formulation increased from 0% to 3.3% and a further addition of ethanol resulted in an increase in average diameter of vesicles. CyA vesicles containing 10% and 20% ethanol showed statistically enhanced deposition of CyA into the stratum corneum (SC), as compared to vesicles prepared without ethanol. CyA vesicles prepared with NAT 8539/ethanol (10/3.3) showed a 2.1-fold, CyA vesicles with NAT 8539/ethanol (10/10) showed a 4.4-fold, and CyA vesicles with NAT 8539/ethanol (10/20) showed a 2.2-fold higher deposition of CyA into SC, as compared to vesicles made of NAT 8539 without ethanol [NAT 8539/ethanol (10/0)]. The efficiency of the formulations was sequenced in the order of: NAT 8539/ethanol (10/10)>NAT 8539/ethanol (10/20)>NAT 8539/ethanol (10/3.3)>ethanol>NAT 8539/ethanol (10/0). These results can be considered a step forward for the topical delivery of problematic molecules like CyA using liposomes as a tool for the treatment of inflammatory skin diseases like psoriasis, atopic dermatitis, and diseases of the hair follicle like alopecia areata, etc. Coyright 2004 Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15147804     DOI: 10.1016/j.jconrel.2004.02.028

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  17 in total

1.  Diclofenac Loaded Lipid Nanovesicles Prepared by Double Solvent Displacement for Skin Drug Delivery.

Authors:  M Sala; F Locher; M Bonvallet; G Agusti; A Elaissari; H Fessi
Journal:  Pharm Res       Date:  2017-06-19       Impact factor: 4.200

2.  Cavamax W7 composite ethosomal gel of clotrimazole for improved topical delivery: development and comparison with ethosomal gel.

Authors:  Nida Akhtar; Kamla Pathak
Journal:  AAPS PharmSciTech       Date:  2012-01-27       Impact factor: 3.246

3.  Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A.

Authors:  Luciana B Lopes; Denise A Ferreira; Daniel de Paula; M Tereza J Garcia; José A Thomazini; Márcia C A Fantini; M Vitória L B Bentley
Journal:  Pharm Res       Date:  2006-05-25       Impact factor: 4.200

4.  Ultraflexible lipid vesicles allow topical absorption of cyclosporin A.

Authors:  Juan J Carreras; Willian E Tapia-Ramirez; Adrian Sala; Antonio J Guillot; Teresa M Garrigues; Ana Melero
Journal:  Drug Deliv Transl Res       Date:  2020-04       Impact factor: 4.617

Review 5.  A comprehensive review on possibilities of treating psoriasis using dermal cyclosporine.

Authors:  Sonia Pandey; Purnima Tripathi; Arti Gupta; Jitendra Singh Yadav
Journal:  Drug Deliv Transl Res       Date:  2021-09-22       Impact factor: 4.617

6.  The Relationship between Solubility and Transdermal Absorption of Tadalafil.

Authors:  Hamed Hamishehkar; Mehdi Khoshbakht; Abolghasem Jouyban; Saeed Ghanbarzadeh
Journal:  Adv Pharm Bull       Date:  2015-09-19

7.  Pluronic F127-tailored lecithin organogel of acyclovir: preclinical evidence of antiviral activity using BALB/c murine model of cutaneous HSV-1 infection.

Authors:  Gajanand Sharma; Bimaldeep Kaur; Kanika Thakur; Akanksha Mahajan; Basant Amarji; Mini P Singh; Om Prakash Katare
Journal:  Drug Deliv Transl Res       Date:  2021-01-23       Impact factor: 4.617

8.  Cyclosporine a-nanosuspension: formulation, characterization and in vivo comparison with a marketed formulation.

Authors:  Mahendra Nakarani; Priyal Patel; Jayvadan Patel; Pankaj Patel; Rayasa S R Murthy; Subhash S Vaghani
Journal:  Sci Pharm       Date:  2010-04-26

9.  Topical delivery of DNA oligonucleotide to induce p53 generation in the skin via thymidine dinucleotide (pTT)-encapsulated liposomal carrier.

Authors:  Yi-Ping Fang
Journal:  Int J Nanomedicine       Date:  2011-12-20

10.  Influence of the flexible liposomes on the skin deposition of a hydrophilic model drug, carboxyfluorescein: dependency on their composition.

Authors:  Mohamed Badran; Khaled Shalaby; Abdullah Al-Omrani
Journal:  ScientificWorldJournal       Date:  2012-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.